SHPMY (Shanghai Pharmaceuticals Holding Co) E10: $0.66 (As of Mar. 2026)


SHPMY Shanghai Pharmaceuticals Holding Co Ltd SHPMY
79 GF Score
Price $7.34
GF Value $9.50
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shanghai Pharmaceuticals Holding Co E10?

Shanghai Pharmaceuticals Holding Co SHPMY -3.42% 79 E10 is $0.66 as of Mar. 2026. GuruFocus rates SHPMY with a GF Score™ of 79/100 and a GF Value™ of $9.50 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shanghai Pharmaceuticals Holding Co's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.276. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.66 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shanghai Pharmaceuticals Holding Co's average E10 Growth Rate was 2.80% per year. During the past 3 years, the average E10 Growth Rate was 1.40% per year. During the past 5 years, the average E10 Growth Rate was 3.20% per year. During the past 10 years, the average E10 Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Shanghai Pharmaceuticals Holding Co was 31.00% per year. The lowest was 1.40% per year. And the median was 15.90% per year.

As of today (2026-06-30), Shanghai Pharmaceuticals Holding Co's current stock price is $7.3398. Shanghai Pharmaceuticals Holding Co's E10 for the quarter that ended in Mar. 2026 was $0.66. Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio of today is 11.12.

During the past 13 years, the highest Shiller PE Ratio of Shanghai Pharmaceuticals Holding Co was 33.20. The lowest was 10.33. And the median was 15.34.


Shanghai Pharmaceuticals Holding Co  (OTCPK:SHPMY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shanghai Pharmaceuticals Holding Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=7.3398/0.66
=11.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Shanghai Pharmaceuticals Holding Co was 33.20. The lowest was 10.33. And the median was 15.34.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Shanghai Pharmaceuticals Holding Co E10 Related Terms


Shanghai Pharmaceuticals Holding Co E10 Historical Data

* Premium members only.

The historical data trend for Shanghai Pharmaceuticals Holding Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pharmaceuticals Holding Co E10 Chart

Shanghai Pharmaceuticals Holding Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.64 0.65 0.61 0.57 0.68

Shanghai Pharmaceuticals Holding Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.57 0.57 0.69 0.68 0.66

SHPMY vs MCK, CAH, COR: E10 Comparison

For the Medical Distribution subindustry, Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Pharmaceuticals Holding Co Shiller PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Pharmaceuticals Holding Co's Shiller PE Ratio falls into.


SHPMY
79GF Score
Shanghai Pharmaceuticals Holding Co Ltd SHPMY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Pharmaceuticals Holding Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Pharmaceuticals Holding Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.276/116.3033*116.3033
=0.276

Current CPI (Mar. 2026) = 116.3033.

Shanghai Pharmaceuticals Holding Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.238 101.400 0.273
201609 0.202 102.400 0.229
201612 0.199 102.600 0.226
201703 0.270 103.200 0.304
201706 0.253 103.100 0.285
201709 0.216 104.100 0.241
201712 0.235 104.500 0.262
201803 0.289 105.300 0.319
201806 0.276 104.900 0.306
201809 0.346 106.600 0.377
201812 0.128 106.500 0.140
201903 0.298 107.700 0.322
201906 0.290 107.700 0.313
201909 0.274 109.800 0.290
201912 0.171 111.200 0.179
202003 0.264 112.300 0.273
202006 0.346 110.400 0.365
202009 0.301 111.700 0.313
202012 0.237 111.500 0.247
202103 0.576 112.662 0.595
202106 0.397 111.769 0.413
202109 0.248 112.215 0.257
202112 0.165 113.108 0.170
202203 0.347 114.335 0.353
202206 0.515 114.558 0.523
202209 0.228 115.339 0.230
202212 0.115 115.116 0.116
202303 0.297 115.116 0.300
202306 0.209 114.558 0.212
202309 0.219 115.339 0.221
202312 -0.007 114.781 -0.007
202403 0.292 115.227 0.295
202406 0.255 114.781 0.258
202409 0.212 115.785 0.213
202412 0.096 114.893 0.097
202503 0.248 115.116 0.251
202506 0.585 114.907 0.592
202509 0.133 115.471 0.134
202512 0.106 115.832 0.106
202603 0.276 116.303 0.276

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.66 mean?
Shanghai Pharmaceuticals Holding Co (SHPMY) has a E10 of $0.66 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors.
Is Shanghai Pharmaceuticals Holding Co's E10 too high?
Shanghai Pharmaceuticals Holding Co's current E10 is $0.66. Overall, Shanghai Pharmaceuticals Holding Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Pharmaceuticals Holding Co's E10 compare to MCK and CAH?
Shanghai Pharmaceuticals Holding Co's E10 of $0.66 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Distribution company?
A good E10 depends on the Medical Distribution industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Shanghai Pharmaceuticals Holding Co and its competitors. Shanghai Pharmaceuticals Holding Co's current E10 is $0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Pharmaceuticals Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co (SHPMY) is currently considered Modestly Undervalued. The stock's GF Value™ is $9.50, compared to a current price of $7.34 — trading 22.7% below its estimated fair value. The current E10 is $0.66. Shanghai Pharmaceuticals Holding Co's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Shanghai Pharmaceuticals Holding Co (SHPMY), the current E10 is $0.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Pharmaceuticals Holding Co (SHPMY) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Pharmaceuticals Holding Co stock appears to be undervalued. The current stock price of $7.34 is trading 22.7% below its estimated GF Value™ of $9.50. GuruFocus considers Shanghai Pharmaceuticals Holding Co to be Modestly Undervalued.

Key valuation signals for SHPMY:

  • E10: $0.66
  • GF Value™: $9.50 vs. price of $7.34 (22.7% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the SHPMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Pharmaceuticals Holding Co Business Description

Address No. 200 Taicang Road, Shanghai Pharmaceutical Building, Shanghai, CHN, 200020
Shanghai Pharmaceuticals Holding Co Ltd is engaged in the pharmaceutical drug development and distribution business. The Group's reportable segments are: Production, Distribution, Retail, and Other. The majority of its revenue comes from the Distribution segment, which is mainly engaged in distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services for pharmaceutical manufacturers and dispensers. The Retail segment operates a network of retail pharmacy stores, and the Production segment is mainly engaged in research and development, production, and sales of a broad range of pharmaceutical and healthcare products. Geographically, the Group mainly operates in the People's Republic of China (PRC).
79GF Score

Get the complete analysis for SHPMY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.34
Price
$9.50
GF Value